不知道中国国内哪里能买得到去纤苷，可以看看这篇文章！

Hepatic veno-occlusive disease (HVOD) is one of the serious complications after hematopoietic stem cell transplantation (HSCT), and the mortality rate in patients with severe HVOD can be as high as 100%. Defibrotide is a mixture of single-stranded oligonucleotides with antithrombotic and fibrinolytic effects. In recent years, multiple clinical research results have shown that defibrotide is a safe and effective drug for preventing and treating HVOD after HSCT. Defibrotide was first developed by Gentium Pharmaceuticals in Italy and was approved for marketing in the EU in October 2013. After Gentium Pharmaceuticals was acquired by Jazz Pharmaceuticals of the United States, defibrotide was approved by the U.S. Food and Drug Administration (FDA) for marketing in the United States on March 30, 2016, under the trade name Defitelio. The recommended dose for adult and pediatric patients is 6.25 mg/kg given as a 2-hour intravenous infusion every 6 hours. The dose should be based on the patient's baseline weight, which is defined as the patient's weight before the HSCT (hematopoietic stem cell transplant) preparation protocol.

目前去纤苷并未获批在中国上市，因此患者是没有办法在国内购买到该药物的，由于本品尚未上市，也就不存在是否进入国家医保这一说。 But I believe that defibrotide will surely land in China in the near future, bringing hope to domestic patients with hepatic veno-occlusive disease. Although defibrotide is not on the market, the disease is at the forefront and medication is urgent. When most people can only spend a lot of manpower and material resources traveling domestically and abroad to purchase drugs, you may wish to find domestic and overseas medical institutions to help you purchase defibrotide. However, according to what Medical Companion Travel currently knows, the specification of defibrinoside is 200 mg and the price is about $21,600. It is more suitable for patients to use for a long time. It is high quality, low price, and saves worry and effort. Currently, fluctuations in market exchange rates directly lead to increases and decreases in drug prices. Therefore, for more information about defibrotide, please ask InfoMed.com to answer your questions.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.